Healthcare -
Drug Manufacturers - General - NASDAQ - UK
$ 76.715
0.663 %
$ 238 B
Market Cap
34.1
P/E
AZN - COST OF REVENUE
Cost of Revenue AZN - AstraZeneca PLC
10.2 B
LAST VALUE
-9.24%
2 YEAR CAGR
15.71%
5 YEAR CAGR
5.74%
10 YEAR CAGR